GCG and metabolic dysfunction-associated steatotic liver disease: NAFLD improvement (More severe versus less severe steatosis OR: 0.001, by ultrasound), BMI, and ↑ in anorexigenic intestinal hormones (including GLP-1 and GLP-2).